Mylan Gets Until April 2020 To Decide On Biosimilar Botox Collaboration With Revance

 
• By Akriti Seth
2020
Revance extends Mylan’s deadline to April 2020 in exchange for $5m • Source: Shutterstock

More from Deals

More from Business